Goldman Sachs Assumes Iovanace Biotherapeutics (IOVA) at Buy

September 24, 2026 4:59 AM

(Updated - September 24, 2026 5:27 AM EDT)

Goldman Sachs analyst Andrea Newkirk assumes coverage on Iovanace Biotherapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found